TrialBone marrow transplantation2011

A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents.

J Styczynski et al.PubMed ↗Publisher ↗

No numbers read from the abstract.